metyrapone has been researched along with Bronze Diabetes in 3 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walsh, CH | 1 |
| Murphy, AL | 1 |
| Cunningham, S | 1 |
| McKenna, TJ | 1 |
| Levy, CL | 1 |
| Carlson, HE | 1 |
| Goossens, JP | 1 |
3 other studies available for metyrapone and Bronze Diabetes
| Article | Year |
|---|---|
Mineralocorticoid and glucocorticoid status in idiopathic haemochromatosis.
Topics: Adult; Aged; Aldosterone; Blood Glucose; Cortodoxone; Cosyntropin; Female; Hemochromatosis; Humans; | 1994 |
Decreased prolactin reserve in hemochromatosis.
Topics: Estradiol; Follicle Stimulating Hormone; Growth Hormone; Hemochromatosis; Hydrocortisone; Levodopa; | 1978 |
Idiopathic haemochromatosis: Juvenile and familial type - endocrine aspects.
Topics: Adult; Aged; Child; Female; Hemochromatosis; Humans; Male; Metyrapone; Middle Aged; Pedigree | 1975 |